Search

Issue
Title
Authors
Applying of magnetic resonance tomography for assessment of cardiac remodeling and risk stratification in patients with pulmonary arterial hypertension
Shariya A.M., Martynyuk T.V., Shariya M.A., Ustyuzhanin D.V.
Socio-economic burden of pulmonary hypertension: relevance of assessment in Russia and the world
Zakiev V.D., Gvozdeva A.D., Martynyuk T.V.
Role of the endothelin receptor antagonist bosentan in the treatment of patients with pulmonary hypertension
Tsareva N.A.
A systematic review as a method of gathering scientific evidence into clinical guidelines: CHEST-2019 guideline for the therapy pulmonary arterial hypertension in adults
Shmalts A.A., Gorbachevsky S.V.
Advantages and limitations of initial combination therapy in pulmonary arterial hypertension patients in Russia
Shmalts A.A., Gorbachevsky S.V.
Combination therapy is a new standard for treatment of pulmonary arterial hypertension
Avdeev S.N., Tsareva N.A., Gaisin I.R.
The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat
Gratsianskaya S.E., Valieva Z.S., Martynyuk T.V.
Evidence base for specific pulmonary vasodilators in adults with congenital heart disease
Shmalts A.A., Gorbachevsky S.V.
New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension
Martynyuk T.V., Nakonechnikov S.N., Chazova I.Y.
Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future
Martynyuk T.V., Chazova I.E.
Modern view on the place of riociguat in the treatment of pulmonary hypertension
Valieva Z.S., Taran I.N., Martynyuk T.V., Chazova I.Y.
Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan
Avdeev S.N.
Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry
Chazova I.E., Arkhipova O.A., Martynyuk T.V.
A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out?
Tsareva N.A., Avdeev S.N., Neklyudova G.V.
First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study
Avdeev S.N., Tsareva N.A., Nekliudova G.V., Chuchalin A.G.
Evolution of pathogenetic therapy of pulmonary arterial hypertension
Chazova I.E., Yarovoy S.Y., Danilov N.M.
Bosentan use in pulmonary arterial hypertension: Russian and foreign experience
Valieva Z.S., Martynyuk T.V., Chazova I.E.
Risk stratification methods and their significance in pulmonary arterial hypertension
Avdeev S.N., Tsareva N.A.
1 - 18 of 18 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies